INIS
accumulation
5%
animals
8%
benchmarks
8%
cancer
11%
carcinogenesis
5%
carcinomas
50%
comparative evaluations
13%
control
8%
copper
10%
copper sulfates
21%
damage
8%
diseases
10%
dna
25%
dna damages
16%
doses
16%
fibroblasts
100%
galactosidase
10%
genes
61%
growth
5%
humans
55%
in vitro
5%
in vivo
16%
induction
8%
inflammation
8%
inhalation
50%
interactions
11%
lung cells
16%
lungs
50%
melanomas
5%
migration
5%
nanomaterials
50%
oxidation
38%
phenotype
16%
populations
5%
proteins
58%
rats
50%
recovery
8%
safety
8%
silica
50%
silver oxides
8%
skin
5%
skin cancer
5%
strand breaks
8%
sun
5%
tissues
50%
titanium oxides
16%
toxicity
50%
transformations
5%
tumor cells
5%
tumors
5%
Keyphrases
Assay Procedure
12%
ATP Assay
12%
Cancer Therapeutics
5%
Caspase 3/7 Activity
12%
Cell Viability Assay
12%
Copper Sulfate
16%
Cutaneous Squamous Cell Carcinoma (cSCC)
50%
E-Group
5%
Human Dermal Fibroblasts
5%
Immune Assay
12%
In Vitro Cytotoxicity
50%
Indirect Coculture
11%
Inflammation Pathway
5%
Interlaboratory Comparison
12%
Isogenic Cell Lines
5%
Malignant Transformation
5%
MTS Assay
12%
Nanosafety Assessment
12%
Non-melanoma Skin Cancer
5%
Nrf2 Transcription Factor
16%
Nuclear Localization
6%
Prion Disease
6%
Prion Protein
50%
Pro-inflammation
50%
Protein Integrity
5%
PrPC
12%
PrPSc
6%
Pulmonary Toxicity
5%
Rapid Development
12%
Scrapie
6%
Senescent Fibroblasts
11%
Silica Nanomaterials
50%
Silver Oxide Nanoparticles
12%
Squamous Carcinoma Cells
50%
Sun Exposure
5%
Well Plate
12%
Pharmacology, Toxicology and Pharmaceutical Science
Adenosine Triphosphate
25%
Caspase 3
25%
Cell Culture
25%
Cell Viability
12%
Copper Oxide Nanoparticle
25%
Cytokine
12%
Cytotoxicity
50%
Enzyme-Linked Immunosorbent Assay
25%
Genotoxicity
50%
Inflammation
54%
Nanomaterial
75%
Nanoparticle
50%
Silicon Dioxide
50%
Silver Nanoparticle
12%
Toxicity
12%
Tumor Necrosis Factor
25%
Viability Assay
12%